Operator
Good afternoon, and welcome to the Judges Scientific Investor Presentation. Today, we are joined by Tim Prestidge, Chief Executive Officer; Brad Ormsby, Chief Financial Officer; and Ian Wilcock, Group Commercial Director. [Operator Instructions]
I will now hand over to Tim to begin the presentation.
Tim Prestidge
CEO & Executive Director
Thank you, Ivy, and welcome, everyone. Thank you for joining and delighted to be leading this, my first retail webinar as CEO. I’m going to start just by saying how the agenda overall will work here and the points that we’re going to cover.
So I’m going to give some introductory remarks and talk a little about the highlights from our financial year 2025, the investments that we’ve made and the key takeaways, talk a little bit about the executive team and our business model. I’m then going to hand over to Brad, who will talk in more detail about the specifics of our performance through 2025. Brad is going to then hand back to myself and my colleague, Ian, to talk through our buy and build — the fundamentals of our buy and build strategy, acquisitions and the organic growth model, after which we’ll talk about some of the fundamentals and finally, some time for Q&A.
So one of the key takeaways that we’ll talk about is undoubtedly the financial year ’25 — 2025 has been a disappointing year, but the fundamentals are intact. So in that context, it probably makes sense to have a chat about what are the fundamentals. So what is Judges Scientific and what is our business model? So Ivy, if you can move
